Back to all departments
Prof. Dr. med. Peter Bartenstein image

Department of nuclear medicine

Prof. Dr. med. Peter Bartenstein
nuclear medicine

About the department

The department of nuclear medicine at University Hospital of the Ludwig-Maximilians-University (LMU) Munich specializes in diagnosing and treating patients with oncology, neurology, and cardiology disease where nuclear medicine can be used. The department proposes a full range of nuclear medicine diagnostics on 17 cameras, including two 3-headed and several 2-headed gamma cameras and three PET/CT devices. Ambitious technology and excerpt knowledge in nuclear medicine can significantly improve diagnostics and therapy of diseases. One of the focuses of the department is preclinical research, where nuclear physicians, physicists, radiochemists and more specialists provide analysis of the new radiopharmaceuticals in diagnosis and therapy before medical application. The number of inpatient cases is more than 1,000 per year. The department is actively practising and involved in clinical trials in LU-177, Ra-223, Ac-225 and I-131 for neoplasms of different origins.

The doctors of the departments provide diagnostics using radioisotope methods, also known as scintigraphy, positron emission tomography, and SPECT-CT. In oncology, nuclear medicine is used for primary tumour diagnostics, general diagnostics, nuclear therapy (LU-177 PSMA therapy), planning and tumour follow-up.

Show more

Treatment and diagnostic focus of the department


  • Benign and malignant thyroid tumours
  • Malignant prostate tumours
  • Neuroendocrine tumours
  • Skeletal metastases
  • Brain diseases
  • Parkinson's disease
  • Alzheimer's disease
  • Heart attack
  • Other pathological conditions where nuclear medicine can be used 


  • Conventional radioisotope diagnostics (scintigraphy)
  • Positron emission tomography (PET)
  • Other diagnostic options


  • Radioactive iodine (I-131) therapy (using small amounts of radioactive material)
  • Radioimmunotherapy (RIT) (combines radiation therapy with the targeting ability of immunotherapy)
  • Radiopeptidetherapy
  • LU-177 PSMA therapy
  • Selective internal radiation therapy (SIRT) (to control cancers in the liver that can't be removed with surgery)
  • MIBG (meta-iodobenzylguanidine) therapy (low-dose radioactive iodine to look for neuroblastoma)
  • Radiosynoviorthesis (RSO) (local application of radioactive agents)
  • Other medical services 
Show more

Doctor profile


  • 1978-1983 Studies of medicine, Universities of Bochum and Bonn
  • 1986-1990 Resident at the Department of Nuclear Medicine, University of Muenster
  • 1990 Professional Board Certification: Nuclear Medicine
  • 1994 Habilitation


  • 1985-1986 Military service as a medical officer in Andernach
  • 1981-1984 Researcher at the Department of Haematology and Oncology, University of Bonn
  • 1991-1994 Attending physician at the Department of Nuclear Medicine, University of Muenster
  • 1994-1999 Attending physician at the Department of Nuclear Medicine, Technical University Munich and Head of the Neuroimaging group
  • 1999-2006 Director of the Department of Nuclear Medicine, Johannes Gutenberg-University Mainz
  • since 2006 Director of the Department of Nuclear Medicine, Ludwig-Maximilian-University Munich

Awards, memberships, publications

  • 1990-1991 Research Fellowship (Deutsche Forschungsgemeinschaft) in the PET-Group of the Medical Research Council Cyclotron Unit, Hammersmith Hospital London
  • Member of German Society of Nuclear Medicine
  • Brain Imaging Council, Society of Nuclear Medicine
  • Since 2009 Steering Committee, BMBF Biotech Clusters
Show more
Send request
Have any questions? Get in touch with the hospital!

Similar hospitals